Skip to content

Luke Evnin, Director at Werewolf Therapeutics, sold HOWL on Jul 6, 2026

Data as of Oct 16

▼ SELL$11.4K35,770 shares at $0.32Luke Evnin DirectorHOWL Werewolf Therapeutics, Inc.
Watch HOWL
Traded
Jul 6, 2026
Disclosed
Jul 8, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Luke Evnin, Director at Werewolf Therapeutics, sold HOWL on Jul 6, 2026TRADEDDISCLOSED
HOWLSimilar stocks (S&P 500 (SPY)), rebased to HOWL's price on the disclosure day
HOWL since disclosure
+172.4%
after the sale
Similar stocks (SPY) since disclosure
+2.4%
S&P 500 (SPY)

Change in closing price from Jul 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLLuke Evnin DirectorHOWL Werewolf Therapeutics, Inc.$33.3Kdisclosed Jul 8 · filed 1 day after the trade

See every trade on HOWL →